The estimated Net Worth of David P Gusky is at least 57.4 千$ dollars as of 14 December 2018. David Gusky owns over 617 units of Avadel Pharmaceuticals plc stock worth over 55,733$ and over the last 8 years David sold AVDL stock worth over 1,654$.
David has made over 1 trades of the Avadel Pharmaceuticals plc stock since 2018, according to the Form 4 filled with the SEC. Most recently David sold 617 units of AVDL stock worth 1,654$ on 14 December 2018.
The largest trade David's ever made was selling 617 units of Avadel Pharmaceuticals plc stock on 14 December 2018 worth over 1,654$. On average, David trades about 103 units every 0 days since 2016. As of 14 December 2018 David still owns at least 4,083 units of Avadel Pharmaceuticals plc stock.
You can see the complete history of David Gusky stock trades at the bottom of the page.
David's mailing address filed with the SEC is C/O FLAMEL TECHNOLOGIES S.A, 33 AVENUE DU DR. GEORGES LEVY, VENISSIEUX, I0, 69200.
Over the last 8 years, insiders at Avadel Pharmaceuticals plc have traded over 7,791,038$ worth of Avadel Pharmaceuticals plc stock and bought 775,568 units worth 4,366,224$ . The most active insiders traders include Healthcare Master Fund Ltd ...、Kevin Broadfin Capital, Llc...、Naseem Amin. On average, Avadel Pharmaceuticals plc executives and independent directors trade stock every 43 days with the average trade being worth of 381,436$. The most recent stock trade was executed by Thomas S Mchugh on 16 January 2024, trading 2,000 units of AVDL stock currently worth 29,000$.
avadel pharmaceuticals plc (nasdaq: avdl) is a specialty pharmaceutical company that seeks to develop differentiated pharmaceutical products that are safe, effective and easy to take, helping patients adhere to their prescribed medical treatment and see better results. avadel’s current portfolio of products and product candidates focuses on the urology, central nervous system (cns) / sleep, and hospital markets. the company is headquartered in dublin, ireland with operations in st. louis, missouri and lyon, france.
Avadel Pharmaceuticals plc executives and other stock owners filed with the SEC include: